CCRCC

Clinical trials for CCRCC explained in plain language.

Never miss a new study

Get alerted when new CCRCC trials appear

Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Terminated 2

New drug trial begins for Tough-to-Treat kidney cancer

Disease control Recruiting now

This is the first study in people testing a new oral drug called NEO-811 for advanced kidney cancer that has spread or cannot be removed by surgery. The main goals are to find a safe dose and see how the body handles the drug. It is for patients whose cancer has continued to grow…

Matched conditions: CCRCC

Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

CCRCC

Get alerted when new CCRCC trials appear

New drug trial begins for Tough-to-Treat kidney cancer